Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business dayGet my quote

Thalassemia (beta and alpha thalassemia): US-approved treatments and how Gulf families can access them

Creator: Reserve Meds
Published: 2026-10-17

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Thalassemia: the short answer

The US FDA has approved four medicines on this page for thalassemia, each for specific patients. Two of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

US FDA-approved medicines on this page: Zynteglo, Casgevy, Reblozyl and Aqvesme.
Gulf registration (checked 17 October 2026): see each medicine below.
Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital; cell and gene therapies at a qualified center.
Price: Quote on request.

What is thalassemia?

Thalassemias are inherited blood disorders in which the body makes less hemoglobin and fewer healthy red blood cells, which leads to anemia. They occur most often among people of Italian, Greek, Middle Eastern, South Asian and African descent.^[1]

Beta thalassemia major (transfusion-dependent thalassemia) appears in the first 2 years of life, with severe anemia, poor growth, jaundice and an enlarged spleen, liver and heart. Many patients need regular blood transfusions, and over time iron builds up and can damage the liver, heart and hormone glands. Alpha thalassemia ranges from HbH disease to the severe Hb Bart form.^{[2, 3]}

Treatment includes transfusions, medicines to remove excess iron and, in some severe cases, a bone marrow transplant. In the US, two one-time gene therapies are approved for transfusion-dependent beta thalassemia, and two medicines treat anemia in thalassemia.^{[1, 4, 5, 6, 7]}

Thalassemia in the Gulf

A 2023 commentary describes thalassemia as a major health challenge in the UAE and discusses how consanguinity, endogamy and limits on reproductive options affect prevention, recommending awareness campaigns and earlier genetic testing.^[8]

US FDA-approved medicines for thalassemia

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

Zynteglo (betibeglogene autotemcel)
FDA-approved for adults and children with beta thalassemia who need regular red blood cell transfusions. It is a one-time gene therapy made from the patient's own blood stem cells, given at a qualified center.^[4]
Given at a qualified treatment center. Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[9, 10]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Jordan
Casgevy (exagamglogene autotemcel)
FDA-approved for patients 2 years and older with transfusion-dependent beta thalassemia, and sickle cell disease with recurrent vaso-occlusive crises. It is a one-time gene-edited therapy given at a qualified center.^[5]
Given at a qualified treatment center. Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[9, 10]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, India, Pakistan
Reblozyl (luspatercept)
FDA-approved for anemia in adults with beta thalassemia who need regular red blood cell transfusions. It is an injection under the skin every 3 weeks. It is also approved for some patients with MDS.^[6]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[9, 10]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, India
Aqvesme (mitapivat)
FDA-approved for anemia in adults with alpha or beta thalassemia. It is a tablet (mitapivat).^[7]
Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[9, 10]}

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.^{[11, 12]} Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

For Zynteglo and Casgevy. These treatments are made for each patient or need a specialized procedure, so treatment happens at a qualified center. For most Gulf families that means a referral from the treating specialist to a center that can give the treatment. A local hospital can only give it if the manufacturer agrees to supply that hospital and the regulator approves. We cannot promise that a manufacturer will agree.

Who does what

Your treating specialist decides whether a medicine is right for the patient and writes the letter.
The hospital checks local supply, files any import request, and gives the treatment safely.
The national regulator decides whether to approve the import of a medicine that is not registered.
The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
Recent clinic notes and a list of current medicines
For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for thalassemia

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Frequently asked questions

Is there an FDA-approved treatment for thalassemia?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Zynteglo, Casgevy, Reblozyl and Aqvesme. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Zynteglo available in Saudi Arabia or the UAE?

Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Zynteglo?

It is given at a qualified center. Your specialist refers the patient, the center checks eligibility, and the family plans funding and travel. A local hospital can only give it if the manufacturer agrees to supply it and the regulator approves.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Is Casgevy available in the Gulf for thalassemia?

Check the register line under Casgevy above and our Casgevy country guides, linked from the medicine card, for the latest sourced status by country.

Why does iron build up in thalassemia?

MedlinePlus Genetics explains that frequent blood transfusions add iron to the body, which can damage the liver, heart and hormone glands over time. That is why iron-removal treatment is part of care.

Sources for the last two answers: ^[5] ^[2]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

This page is general health information, not medical advice. It does not replace a consultation with your doctor.